Commonwealth Equity Services’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $292K | Sell |
|
|||||
|
2025
Q2 | $944K | Buy |
|
|||||
|
2025
Q1 | $724K | Buy |
|
|||||
|
2024
Q4 | $795K | Buy |
|
|||||
|
2024
Q3 | $230K | Buy |
|
|||||
|
2024
Q2 | $240K | Buy |
|
|||||
|
2024
Q1 | $259K | Sell |
|
|||||
|
2023
Q4 | $445K | Buy |
|
|||||
|
2023
Q3 | $284K | Sell |
|
|||||
|
2023
Q2 | $346K | Buy |
|
|||||
|
2023
Q1 | $267 | Buy |
|
|||||
|
2022
Q4 | $221K | Buy |
|
|||||
|
2022
Q3 | $213K | Sell |
|
|||||
|
2022
Q2 | $190K | Buy |
|
|||||
|
2022
Q1 | $325K | Sell |
|
|||||
|
2021
Q4 | $328K | Sell |
|
|||||
|
2021
Q3 | $238K | Sell |
|
|||||
|
2021
Q2 | $378K | Sell |
|
|||||
|
2021
Q1 | $404K | Sell |
|
|||||
|
2020
Q4 | $844K | Buy |
|
|||||
|
2020
Q3 | $635K | Buy |
|
|||||
|
2020
Q2 | $686K | Sell |
|
|||||
|
2020
Q1 | $622K | Buy |
|
|||||
|
2019
Q4 | $623K | Buy |
|
|||||
|
2019
Q3 | $465K | Sell |
|
|||||
|
2019
Q2 | $368K | Sell |
|
|||||
|
2019
Q1 | $371K | Sell |
|
|||||
|
2018
Q4 | $225K | Sell |
|
|||||
|
2018
Q3 | $290K | Buy |
|
|||||
|
2018
Q2 | $206K | Sell |
|
|||||
|
2018
Q1 | $314K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $466K | Buy |
|
|||||
|
2016
Q1 | $322K | Buy |
|
|||||
|
2015
Q4 | $344K | Hold |
|
|||||
|
2015
Q3 | $319K | Buy |
|
|||||
|
2015
Q2 | $324K | Sell |
|
|||||
|
2015
Q1 | $276K | Sell |
|
|||||
|
2014
Q4 | $276K | Buy |
|